Suppr超能文献

持续非卧床腹膜透析患者的腹膜巨噬细胞在腹膜炎期间释放肿瘤坏死因子的能力增强。

Peritoneal macrophages from patients on continuous ambulatory peritoneal dialysis have an increased capability to release tumour necrosis factor during peritonitis.

作者信息

Fieren M W, van den Bemd G J, Bonta I L, Ben-Efraim S

机构信息

Department of Internal Medicine I, University Hospital Dijkzigt, Erasmus University Rotterdam, The Netherlands.

出版信息

J Clin Lab Immunol. 1991 Jan;34(1):1-9.

PMID:1667936
Abstract

We have reported previously that human peritoneal macrophages collected from patients on Continuous Ambulatory Peritoneal Dialysis (CAPD) during an episode of peritonitis secrete increased amounts of interleukin-1 (IL-1), as compared to those collected during an infection free period, provided the cells were stimulated in vitro by LPS. We now report that such macrophages release also higher amounts of Tumor Necrosis Factor (TNF), if collected during peritonitis and stimulated subsequently in vitro by LPS. The increase in release of TNF was ascertained by radio-immunoassays as well as by bioassay of cytostatic effect against the highly sensitive TNF target-cell line L929 murine transformed fibroblasts. The present reported results, in addition to previously reported data on release of IL-1, indicate that induction of release of cytokines from human peritoneal macrophages is a dual stepwise process: first priming in vivo in an inflammatory environment and, secondly stimulation in vitro by LPS.

摘要

我们先前曾报道,与在无感染期收集的人类腹膜巨噬细胞相比,在腹膜炎发作期间从持续非卧床腹膜透析(CAPD)患者身上收集的人类腹膜巨噬细胞,在体外经脂多糖(LPS)刺激后,会分泌更多的白细胞介素-1(IL-1)。我们现在报告,如果在腹膜炎期间收集此类巨噬细胞并随后在体外经LPS刺激,它们还会释放更高量的肿瘤坏死因子(TNF)。TNF释放的增加通过放射免疫测定以及对高度敏感的TNF靶细胞系L929小鼠转化成纤维细胞的细胞抑制作用生物测定来确定。除了先前报道的关于IL-1释放的数据外,本报告结果表明,人类腹膜巨噬细胞细胞因子释放的诱导是一个双步骤过程:首先在体内炎症环境中启动,其次在体外经LPS刺激。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验